The National Vaccine Program Office annually awards
funds to support vaccine- and immunization-related
projects to the Federal agencies that participate in
the Inter-Agency Vaccine Group. These funds are used
to provide short-term support for research
activities that address priority areas consistent
with the National Vaccine Plan. For fiscal year
2005, priority areas for funding included:
PRIORITIES FOR 2005 UNMET NEEDS FUNDING
For FY 2005, specific NVPO Unmet Needs priority areas are:
1. Adolescent vaccination
Specifically, related to implementation of current and future
vaccines among adolescents including programmatic, legal, and vaccine
delivery system issues.
2. Future vaccines for emerging infections (e.g., SARS, West Nile
Virus) or with expected U.S. licensure in 3-years (e.g., meningococcal
conjugate, rotavirus, HPV)
Specifically, studies contributing to vaccine development,
evaluation, licensure, and recommendation for emerging infections that
pose a new threat to domestic U.S. populations, not including
bioterrorist threats or HIV, and for those vaccines with near term U.S.
licensure.
3. Influenza - annual and/or pandemic
4. Vaccine and immunization safety
5. Vaccine supply, financing, and economic analysis